Celyad Oncology SA - Publication of a rectified transparency notification received from Fortress Investment Group LLC

Belgium - Celyad Oncology SA (Euronext: CYAD) ('Celyad Oncology' or the 'Company') today announced, in accordance with Article 14 of the Belgian Law of 2 May 2007 regarding the publication of major shareholdings in issuers whose securities are admitted to trading on a regulated market, that it received a rectified notification of transparency dated September 13, 2023, indicating that CFIP CLYD (UK) Limited, an affiliate of Fortress Investment Group LLC, has crossed the statutory threshold of 25%, holding 7,954,808 shares i.e. 29.99% of Celyad Oncology's shares and 27.53% voting rights as of September 4, 2023.

Additional information

This transparency notification covers the following transactions: sale of 6,500,000 shares of Celyad Oncology from CFIP CLYD LLC to CFIP CLYD (UK) Limited on 30 August 2023 within the scope of an intragroup share transfer and subscription to 1,454,808 newly issued shares of Celyad Oncology by CFIP CLYD (UK) Limited on 4 September 2023.

After both transactions, CFIP CLYD (UK) Limited will hold 7,954,808 shares of Celyad Oncology.

Contact:

Tel: [phone]

Fax: [phone]

Email: [e-mail]

(C) 2023 Electronic News Publishing, source ENP Newswire